Improving Outcomes for Severe Sepsis and Septic Shock: Tools for Early Identification of At-Risk Patients and Treatment Protocol Implementation

Critical Care Clinics

Volumn 24, Issue 3 SUPPL., 2008, Pages 1-47

  Rivers, Emanuel P ^a   Ahrens, Tom ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; ANTITHROMBIN; AZTREONAM; BICARBONATE; CILASTATIN PLUS IMIPENEM; CORTICOSTEROID; D DIMER; DROTRECOGIN; GENTAMICIN; INOTROPIC AGENT; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; LEVOFLOXACIN; LINEZOLID; PIPERACILLIN PLUS TAZOBACTAM; PLASMINOGEN ACTIVATOR INHIBITOR; PROCALCITONIN; PROTEIN C; PROTEIN S; THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR; THROMBOMODULIN; TUMOR NECROSIS FACTOR ALPHA; VANCOMYCIN;

ANTIBIOTIC THERAPY; ARTIFICIAL VENTILATION; AWARENESS; BLOOD CLOTTING DISORDER; CLINICAL PROTOCOL; CORTICOSTEROID THERAPY; COST OF ILLNESS; EARLY DIAGNOSIS; EDEMA; EVIDENCE BASED MEDICINE; FEVER; FLUID THERAPY; GOOD CLINICAL PRACTICE; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH EDUCATION; HIGH RISK PATIENT; HUMAN; HYPERBILIRUBINEMIA; HYPERGLYCEMIA; HYPERLACTATEMIA; HYPOTENSION; HYPOTHERMIA; HYPOXEMIA; INCIDENCE; INFECTION CONTROL; LEUKOCYTOSIS; LEUKOPENIA; LOW DRUG DOSE; MENTAL DISEASE; MORTALITY; MULTIPLE ORGAN FAILURE; OLIGURIA; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RESUSCITATION; REVIEW; RISK FACTOR; SCORING SYSTEM; SEPSIS; SEPTIC SHOCK; SEPTICEMIA; STANDARD; TACHYCARDIA; TACHYPNEA; THROMBOCYTOPENIA; THROMBOSIS PREVENTION; TREATMENT INDICATION; TREATMENT PLANNING;

CLINICAL PROTOCOLS; EARLY DIAGNOSIS; GUIDELINE ADHERENCE; HEALTH PLAN IMPLEMENTATION; HUMANS; PRACTICE GUIDELINES AS TOPIC; QUALITY ASSURANCE, HEALTH CARE; RISK ASSESSMENT; SEPSIS; SHOCK, SEPTIC; UNITED STATES;

EID: 46849108706     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccc.2008.04.002     Document Type: Review

References (107)

1. Minino A.M., Heron M.P., Murphy S.L., et al. Deaths: final data for 2004. Natl Vital Stat Rep 55 19 (2007) 1-119
2. Angus D.C., Linde-Zwirble W.T., Lidicker J., et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29 7 (2001) 1303-1310
3. Martin G.S., Mannino D.M., Eaton S., et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348 16 (2003) 1546-1554
4. Levy M.M., Pronovost P.J., Dellinger R.P., et al. Sepsis change bundles: converting guidelines into meaningful change in behavior and clinical outcome. Crit Care Med 32 Suppl 11 (2004) S595-S597
5. Townsend S, Dellinger RP, Levy MM, et al, editors. Implementing the Surviving Sepsis Campaign. Des Plaines, Brussels, and Land O Lakes: Society of Critical Care Medicine, European Society of Intensive Care, and International Sepsis Forum; 2005.
6. Dellinger R.P., Levy M.M., Carlet J.M., et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 36 1 (2008) 296-327
7. Dellinger R.P., Levy M.M., Carlet J.M., et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 34 1 (2008) 17-60
8. Fong J.J., Cecere K., Unterborn J., et al. Factors influencing variability in compliance rates and clinical outcomes among three different severe sepsis bundles. Ann Pharmacother 41 6 (2007) 929-936
9. Sepsis care enters new era. Available at:. http://www.ihi.org/IHI/Topics/CriticalCare/Sepsis/ImprovementStories/SepsisCareEntersNewEra.htm Accessed March 14, 2008
10. Sebat F., Johnson D., Musthafa A.A., et al. A multidisciplinary community hospital program for early and rapid resuscitation of shock in nontrauma patients. Chest 127 5 (2005) 1729-1743
11. Otero R.M., Nguyen H.B., Huang D.T., et al. Early goal-directed therapy in severe sepsis and septic shock revisited: concepts, controversies, and contemporary findings. Chest 130 5 (2006) 1579-1595
12. Picard K.M., O'Donoghue S.C., Young-Kershaw D.A., et al. Development and implementation of a multidisciplinary sepsis protocol. Crit Care Nurse 26 3 (2006) 43-54
13. Summary of recommendations. Intensive Care Med 27 Suppl 1 (2001) S128-S134
14. Poeze M., Ramsay G., Gerlach H., et al. An international sepsis survey: a study of doctors' knowledge and perception about sepsis. Crit Care 8 6 (2004) R409-R413
15. Bone R.C., Balk R.A., Cerra F.B., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101 6 (1992) 1644-1655
16. Levy M.M., Fink M.P., Marshall J.C., et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31 4 (2003) 1250-1256
17. Alberti C., Brun-Buisson C., Chevret S., et al. Systemic inflammatory response and progression to severe sepsis in critically ill infected patients. Am J Respir Crit Care Med 171 5 (2005) 461-468
18. Sprung C.L., Annane D., Keh D., et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med 358 2 (2008) 111-124
19. Abraham E., Laterre P.F., Garg R., et al. Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. N Engl J Med 353 13 (2005) 1332-1341
20. Vincent J.L., Bernard G.R., Beale R., et al. Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: further evidence for survival and safety and implications for early treatment. Crit Care Med 33 10 (2005) 2266-2277
21. Bernard G.R., Vincent J.L., Laterre P.F., et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344 10 (2001) 699-709
22. Bernard G.R. Drotrecogin alfa (activated) (recombinant human activated protein C) for the treatment of severe sepsis. Crit Care Med 31 Suppl 1 (2003) S85-S93
23. Rivers E., Nguyen B., Havstad S., et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345 19 (2001) 1368-1377
24. Kumar A., Roberts D., Wood K.E., et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34 6 (2006) 1589-1596
25. Morrell M., Fraser V.J., and Kollef M.H. Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 49 9 (2005) 3640-3645
26. Hargrove J., and Nguyen H.B. Bench-to-bedside review: outcome predictions for critically ill patients in the emergency department. Crit Care 9 4 (2005) 376-383
27. Implement the 6-hour bundle. Available at:. http://www.survivingsepsis.org/6hr_bundles Accessed February 2, 2008
28. Implement the 24-hour bundle. Available at:. http://www.survivingsepsis.org/24hr_bundles Accessed February 2, 2008
29. Danai P.A., Moss M., Mannino D.M., et al. The epidemiology of sepsis in patients with malignancy. Chest 129 6 (2006) 1432-1440
30. Ahrens T. Hemodynamics in sepsis. AACN Adv Crit Care 17 4 (2006) 435-445
31. Levy M.M., Macias W.L., Vincent J.L., et al. Early changes in organ function predict eventual survival in severe sepsis. Crit Care Med 33 10 (2005) 2194-2201
32. Nguyen H.B., Rivers E.P., Knoblich B.P., et al. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med 32 8 (2004) 1637-1642
33. Shapiro N.I., Howell M.D., Talmor D., et al. Serum lactate as a predictor of mortality in emergency department patients with infection. Ann Emerg Med 45 5 (2005) 524-528
34. Trzeciak S., Dellinger R.P., Chansky M.E., et al. Serum lactate as a predictor of mortality in patients with infection. Intensive Care Med 33 6 (2007) 970-977
35. Ahrens T., and Tuggle D. Surviving severe sepsis: early recognition and treatment. Crit Care Nurse Suppl 2-13 (2004) 14-15
36. Vincent J.L., de Mendonca A., Cantraine F., et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med 26 11 (1998) 1793-1800
37. Rivers E.P., McIntyre L., Morro D.C., et al. Early and innovative interventions for severe sepsis and septic shock: taking advantage of a window of opportunity. CMAJ 173 9 (2005) 1054-1065
38. Evaluation for severe sepsis screening tool. Available at:. http://www.survivingsepsis.org/files/Tools/evaluationforseveresepsisscreeningtool.pdf Accessed February 2, 2008
39. Dombrovskiy V.Y., Martin A.A., Sunderram J., et al. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med 35 5 (2007) 1244-1250
40. ICU scores. Available at:. http://www.icumedicus.com/icu_scores/index.php Accessed May 28, 2008
41. Scoring systems for ICU and surgical patients. Available at:. http://www.sfar.org/t/spip.php?article60 Accessed February 5, 2008
42. Xigris (drotrecogin alfa activated) prescribing information. Available at:. http://pi.lilly.com/us/xigris.pdf Accessed February 2, 2008
43. Shapiro N.I., Wolfe R.E., Moore R.B., et al. Mortality in Emergency Department Sepsis (MEDS) score: a prospectively derived and validated clinical prediction rule. Crit Care Med 31 3 (2003) 670-675
44. Dellinger R.P., Carlet J.M., Masur H., et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32 3 (2004) 858-873
45. Shapiro N.I., Howell M., and Talmor D. A blueprint for a sepsis protocol. Acad Emerg Med 12 4 (2005) 352-359
46. Rady M.Y., Rivers E.P., and Nowak R.M. Resuscitation of the critically ill in the ED: responses of blood pressure, heart rate, shock index, central venous oxygen saturation, and lactate. Am J Emerg Med 14 2 (1996) 218-225
47. Boldt J. Clinical review: hemodynamic monitoring in the intensive care unit. Crit Care 6 1 (2002) 52-59
48. Cholley B.P., and Payen D. Noninvasive techniques for measurements of cardiac output. Curr Opin Crit Care 11 5 (2005) 424-429
49. Rady M.Y. Bench-to-bedside review: resuscitation in the emergency department. Crit Care 9 2 (2005) 170-176
50. Wheeler A.P., Bernard G.R., Thompson B.T., et al. Pulmonary artery versus central venous catheter to guide treatment of acute lung injury. N Engl J Med 354 21 (2006) 2213-2224
51. Kinasewitz G.T., Yan S.B., Basson B., et al. Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569]. Crit Care 8 2 (2004) R82-R90
52. Shorr A.F., Bernard G.R., Dhainaut J.F., et al. Protein C concentrations in severe sepsis: an early directional change in plasma levels predicts outcome. Crit Care 10 3 (2006) R92
53. Yan S.B., Helterbrand J.D., Hartman D.L., et al. Low levels of protein C are associated with poor outcome in severe sepsis. Chest 120 3 (2001) 915-922
54. Bernard G., Artigas A., Dellinger P., et al. Clinical expert round table discussion (session 3) at the Margaux Conference on Critical Illness: the role of activated protein C in severe sepsis. Crit Care Med 29 Suppl 7 (2001) S75-S77
55. Stallone J.N. Predicting mortality from sepsis: is protein C a true crystal ball?. Crit Care Med 32 7 (2004) 1620-1621
56. Jones A.E., Fiechtl J.F., Brown M.D., et al. Procalcitonin test in the diagnosis of bacteremia: a meta-analysis. Ann Emerg Med 50 1 (2007) 34-41
57. Tang B.M., Eslick G.D., Craig J.C., et al. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 7 3 (2007) 210-217
58. Uzzan B., Cohen R., Nicolas P., et al. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 34 7 (2006) 1996-2003
59. Charles P.E., Dalle F., Aho S., et al. Serum procalcitonin measurement contribution to the early diagnosis of candidemia in critically ill patients. Intensive Care Med 32 10 (2006) 1577-1583
60. Dahaba A.A., Hagara B., Fall A., et al. Procalcitonin for early prediction of survival outcome in postoperative critically ill patients with severe sepsis. Br J Anaesth 97 4 (2006) 503-508
61. Gibot S., Cravoisy A., Dupays R., et al. Combined measurement of procalcitonin and soluble TREM-1 in the diagnosis of nosocomial sepsis. Scand J Infect Dis 39 6-7 (2007) 604-608
62. Heper Y., Akalin E.H., Mistik R., et al. Evaluation of serum C-reactive protein, procalcitonin, tumor necrosis factor alpha, and interleukin-10 levels as diagnostic and prognostic parameters in patients with community-acquired sepsis, severe sepsis, and septic shock. Eur J Clin Microbiol Infect Dis 25 8 (2006) 481-491
63. Muthiah K.A., Rachakonda K.S., Davis M.J., et al. Prospective evaluation of procalcitonin in sepsis in the Illawarra area of Australia: PEPSIA study. Crit Care Resusc 9 2 (2007) 137-142
64. Novotny A., Emmanuel K., Matevossian E., et al. Use of procalcitonin for early prediction of lethal outcome of postoperative sepsis. Am J Surg 194 1 (2007) 35-39
65. Rau B.M., Frigerio I., Buchler M.W., et al. Evaluation of procalcitonin for predicting septic multiorgan failure and overall prognosis in secondary peritonitis: a prospective, international multicenter study. Arch Surg 142 2 (2007) 134-142
66. Schneider H.G., and Lam Q.T. Procalcitonin for the clinical laboratory: a review. Pathology 39 4 (2007) 383-390
67. Lomas-Neira J.L., and Ayala A. CXCL2 polymorphism in sepsis and acute respiratory distress syndrome: pathological significance lost in translation. Crit Care Med 35 10 (2007) 2439-2440
68. Jessen K.M., Lindboe S.B., Petersen A.L., et al. Common TNF-alpha, IL-1 beta, PAI-1, uPA CD14 and TLR4 polymorphisms are not associated with disease severity or outcome from gram-negative sepsis. BMC Infect Dis 7 (2007) 108
69. Trzeciak S., Dellinger R.P., Parrillo J.E., et al. Early microcirculatory perfusion derangements in patients with severe sepsis and septic shock: relationship to hemodynamics, oxygen transport, and survival. Ann Emerg Med 49 1 (2007) 88-98 98 e81-e82
70. Tenover F.C. Rapid detection and identification of bacterial pathogens using novel molecular technologies: infection control and beyond. Clin Infect Dis 44 3 (2007) 418-423
71. Dellinger R.P., and Schorr C. Severe sepsis in an emergency department: prevalence, rapid identification, and appropriate treatment. Crit Care Med 35 10 (2007) 2461-2462
72. Howell M.D., and Shapiro N.I. Surviving sepsis outside the intensive care unit. Crit Care Med 35 5 (2007) 1422-1423
73. Potential Get With the Guidelines - Stroke Team Members. Available at:. http://www.americanheart.org/downloadable/heart/1083359177585Potential_TeamMembers.pdf Accessed February 12, 2008
74. Get with the guidelines overview. Available at:. http://www.americanheart.org/presenter.jhtml?identifier=3045578 Accessed February 13, 2008
75. Ellrodt G., Glasener R., Cadorette B., et al. Multidisciplinary rounds (MDR): an implementation system for sustained improvement in the American Heart Association's Get With the Guidelines program. Crit Pathw Cardiol 6 3 (2007) 106-116
76. Stoeckle-Roberts S., Reeves M.J., Jacobs B.S., et al. Closing gaps between evidence-based stroke care guidelines and practices with a collaborative quality improvement project. Jt Comm J Qual Patient Saf 32 9 (2006) 517-527
77. Acute myocardial infarction GAP project in Michigan. Available at:. http://www.acc.org/qualityandscience/gap/mi/ami_gap.htm Accessed February 13, 2008
78. Eagle K.A., Montoye C.K., Riba A.L., et al. Guideline-based standardized care is associated with substantially lower mortality in Medicare patients with acute myocardial infarction: the American College of Cardiology's Guidelines Applied in Practice (GAP) projects in Michigan. J Am Coll Cardiol 46 7 (2005) 1242-1248
79. Mehta R.H., Montoye C.K., Faul J., et al. Enhancing quality of care for acute myocardial infarction: shifting the focus of improvement from key indicators to process of care and tool use: the American College of Cardiology Acute Myocardial Infarction Guidelines Applied in Practice Project in Michigan: Flint and Saginaw expansion. J Am Coll Cardiol 43 12 (2004) 2166-2173
80. Mehta R.H., Montoye C.K., Gallogly M., et al. Improving quality of care for acute myocardial infarction: the guidelines applied in practice (GAP) initiative. JAMA 287 10 (2002) 1269-1276
81. Shapiro N.I., Howell M.D., Talmor D., et al. Implementation and outcomes of the multiple urgent sepsis therapies (MUST) protocol. Crit Care Med 34 4 (2006) 1025-1032
82. El Solh A.A., Akinnusi M.E., Alsawalha L.N., et al. Outcome of septic shock in older adults after implementation of the sepsis bundle. J Am Geriatr Soc 56 2 (2008) 272-278
83. Gao F., Melody T., Daniels D.F., et al. The impact of compliance with 6-hour and 24-hour sepsis bundles on hospital mortality in patients with severe sepsis: a prospective observational study. Crit Care 9 6 (2005) R764-R770
84. Jones A.E., Focht A., Horton J.M., et al. Prospective external validation of the clinical effectiveness of an emergency department-based early goal-directed therapy protocol for severe sepsis and septic shock. Chest 132 2 (2007) 425-432
85. Kortgen A., Niederprum P., and Bauer M. Implementation of an evidence-based standard operating procedure and outcome in septic shock. Crit Care Med 34 4 (2006) 943-949
86. Lin S.M., Huang C.D., Lin H.C., et al. A modified goal-directed protocol improves clinical outcomes in intensive care unit patients with septic shock: a randomized controlled trial. Shock 26 6 (2006) 551-557
87. Micek S.T., Roubinian N., Heuring T., et al. Before-after study of a standardized hospital order set for the management of septic shock. Crit Care Med 34 11 (2006) 2707-2713
88. Nguyen H.B., Corbett S.W., Steele R., et al. Implementation of a bundle of quality indicators for the early management of severe sepsis and septic shock is associated with decreased mortality. Crit Care Med 35 4 (2007) 1105-1112
89. Sebat F., Musthafa A.A., Johnson D., et al. Effect of a rapid response system for patients in shock on time to treatment and mortality during 5 years. Crit Care Med 35 11 (2007) 2568-2575
90. Trzeciak S., Dellinger R.P., Abate N.L., et al. Translating research to clinical practice: a 1-year experience with implementing early goal-directed therapy for septic shock in the emergency department. Chest 129 2 (2006) 225-232
91. Qu H.P., Qin S., Min D., et al. The effects of earlier resuscitation on following therapeutic response in sepsis with hypoperfusion. Zhonghua Wai Ke Za Zhi 44 17 (2006) 1193-1196 [in Chinese]
92. Rivers E.P., Coba V., and Whitmill M. Early goal-directed therapy in severe sepsis and septic shock: a contemporary review of the literature. Curr Opion Anaesthesiol 21 2 (2008) 128-140
93. Andrews R.M., and Elixhauser A. The National Hospital Bill: growth trends and 2005 update on the most expensive conditions by payer. Available at:. http://www.hcup-us.ahrq.gov/reports/statbriefs/sb42.pdf Accessed March 14, 2008
94. Huang D.T., Clermont G., Dremsizov T.T., et al. Implementation of early goal-directed therapy for severe sepsis and septic shock: a decision analysis. Crit Care Med 35 9 (2007) 2090-2100
95. Shorr A.F., Micek S.T., Jackson Jr. W.L., et al. Economic implications of an evidence-based sepsis protocol: can we improve outcomes and lower costs?. Crit Care Med 35 5 (2007) 1257-1262
96. Wood K.A., and Angus D.C. Pharmacoeconomic implications of new therapies in sepsis. Pharmacoeconomics 22 14 (2004) 895-906
97. Yu D.T., Black E., Sands K.E., et al. Severe sepsis: variation in resource and therapeutic modality use among academic centers. Crit Care 7 3 (2003) R24-R34
98. Sepsis. Available at:. http://www.ihi.org/IHI/Topics/CriticalCare/Sepsis/ Accessed February 12, 2008
99. Severe sepsis bundles. Available at:. http://www.survivingsepsis.org/implement/bundles Accessed February 12, 2008
100. Langley G.J., Nolan K.M., Nolan T.W., et al. The improvement guide: a practical approach to enhancing organizational performance (1996), Jossey-Bass Publishers, San Francisco (CA)
101. How to improve. Available at:. http://www.survivingsepsis.org/how_to_improve Accessed February 13, 2008
102. How to improve. Available at:. http://www.ihi.org/IHI/Topics/Improvement/ImprovementMethods/HowToImprove/ Accessed February 13, 2008
103. Tools. Available at:. http://www.ihi.org/IHI/Topics/CriticalCare/Sepsis/Tools/ Accessed February 12, 2008
104. Measures. Available at:. http://www.ihi.org/IHI/Topics/CriticalCare/Sepsis/Measures/ Accessed February 13, 2008
105. ICU scores: acute physiology and chronic health evaluation IV. Available at:. http://www.icumedicus.com/icu_scores/apacheIV.php Accessed February 5, 2008
106. ICU scores: new simplified acute physiology score (SAPS II). Available at:. http://www.icumedicus.com/icu_scores/saps.php Accessed February 5, 2008
107. Marshall J.C., Cook D.J., Christou N.V., et al. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med 23 10 (1995) 1638-1652